dexamethasone implant Search Results


dexamethasone-eluting implants (dex-ci  (Cochlear Limited)
90
Cochlear Limited dexamethasone-eluting implants (dex-ci
Dexamethasone Eluting Implants (Dex Ci, supplied by Cochlear Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexamethasone+implant/dexamethasone+eluting+implants++dex+ci/med_rxiv__2024__10__11__24315311-42-15-19
Average 90 stars, based on 1 article reviews
dexamethasone-eluting implants (dex-ci - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
dexamethasone intravitreal implant ozurdex  (AbbVie Inc)
90
AbbVie Inc dexamethasone intravitreal implant ozurdex
Dexamethasone Intravitreal Implant Ozurdex, supplied by AbbVie Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexamethasone+implant/dexamethasone+implant+ozurdex/pm40571045-183-0-8
Average 90 stars, based on 1 article reviews
dexamethasone intravitreal implant ozurdex - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
dexamethasone intravitreal implants  (BioMimetic Therapeutics)
90
BioMimetic Therapeutics dexamethasone intravitreal implants
Dexamethasone Intravitreal Implants, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexamethasone+implant/dexamethasone+intravitreal+implants/pmc05342906-44-30-3
Average 90 stars, based on 1 article reviews
dexamethasone intravitreal implants - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
dexamethasone implant  (Genentech inc)
90
Genentech inc dexamethasone implant
Traditional routes of <t> dexamethasone </t> administration provide suboptimal vitreous levels and high systemic concentrations
Dexamethasone Implant, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexamethasone+implant/dexamethasone+implant/pmc03045060-86-1-24
Average 90 stars, based on 1 article reviews
dexamethasone implant - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
intravitreal dexamethasone implant  (Verlag GmbH)
90
Verlag GmbH intravitreal dexamethasone implant
Traditional routes of <t> dexamethasone </t> administration provide suboptimal vitreous levels and high systemic concentrations
Intravitreal Dexamethasone Implant, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexamethasone+implant/intravitreal+dexamethasone+implant/pm36735142-3-13-35
Average 90 stars, based on 1 article reviews
intravitreal dexamethasone implant - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
dexamethasone intravitreal implant  (AstraZeneca ltd)
90
AstraZeneca ltd dexamethasone intravitreal implant
A summary of patients’ demographics, comorbidities, presentation, and treatment responses.
Dexamethasone Intravitreal Implant, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexamethasone+implant/intravitreal+dexamethasone+implant/pmc10459858-10-19-9
Average 90 stars, based on 1 article reviews
dexamethasone intravitreal implant - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
biodegradable intravitreal implant containing of the corticosteroid dexamethasone  (Oculex Pharmaceuticals Inc)
90
Oculex Pharmaceuticals Inc biodegradable intravitreal implant containing of the corticosteroid dexamethasone
A summary of patients’ demographics, comorbidities, presentation, and treatment responses.
Biodegradable Intravitreal Implant Containing Of The Corticosteroid Dexamethasone, supplied by Oculex Pharmaceuticals Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexamethasone+implant/biodegradable+intravitreal+implant+containing+of+the+corticosteroid+dexamethasone/us09820995-51-24-4
Average 90 stars, based on 1 article reviews
biodegradable intravitreal implant containing of the corticosteroid dexamethasone - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
dexamethasone intravitreous implants  (InProcess Instruments GmbH)
90
InProcess Instruments GmbH dexamethasone intravitreous implants
A summary of patients’ demographics, comorbidities, presentation, and treatment responses.
Dexamethasone Intravitreous Implants, supplied by InProcess Instruments GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexamethasone+implant/dexamethasone+intravitreous+implants/pmc07881366__jamaophthalmol___e210146___s001-65-174-219
Average 90 stars, based on 1 article reviews
dexamethasone intravitreous implants - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
intraocular biodegradable pellet of 60mg dexamethasone for sustained release surodex  (Oculex Pharmaceuticals Inc)
90
Oculex Pharmaceuticals Inc intraocular biodegradable pellet of 60mg dexamethasone for sustained release surodex
A summary of patients’ demographics, comorbidities, presentation, and treatment responses.
Intraocular Biodegradable Pellet Of 60mg Dexamethasone For Sustained Release Surodex, supplied by Oculex Pharmaceuticals Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexamethasone+implant/sustained+release+60mg+dexamethasone+implant/10__1097_slash_iio__0000000000000122-131-70-72
Average 90 stars, based on 1 article reviews
intraocular biodegradable pellet of 60mg dexamethasone for sustained release surodex - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
intravenous (iv) dexamethasone  (Joint Implant Surgeons Inc)
90
Joint Implant Surgeons Inc intravenous (iv) dexamethasone
A summary of patients’ demographics, comorbidities, presentation, and treatment responses.
Intravenous (Iv) Dexamethasone, supplied by Joint Implant Surgeons Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexamethasone+implant/intravenous++iv++dexamethasone/pm15534532-30-31-73
Average 90 stars, based on 1 article reviews
intravenous (iv) dexamethasone - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
verisome® triamcinolone or dexamethasone injectable liquid implant containing plga and non-polymer excipients (benzyl benzoate)  (Santen SAS)
90
Santen SAS verisome® triamcinolone or dexamethasone injectable liquid implant containing plga and non-polymer excipients (benzyl benzoate)
A summary of patients’ demographics, comorbidities, presentation, and treatment responses.
Verisome® Triamcinolone Or Dexamethasone Injectable Liquid Implant Containing Plga And Non Polymer Excipients (Benzyl Benzoate), supplied by Santen SAS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexamethasone+implant/verisome++triamcinolone+or+dexamethasone+injectable+liquid+implant+containing+plga+and+non+polymer+excipients++benzyl+benzoate+/pm30255364-39-14-4
Average 90 stars, based on 1 article reviews
verisome® triamcinolone or dexamethasone injectable liquid implant containing plga and non-polymer excipients (benzyl benzoate) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
dexamethasone implant  (Psivida Inc)
90
Psivida Inc dexamethasone implant
A summary of patients’ demographics, comorbidities, presentation, and treatment responses.
Dexamethasone Implant, supplied by Psivida Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexamethasone+implant/dexamethasone+implant/pm25155371-158-14-25
Average 90 stars, based on 1 article reviews
dexamethasone implant - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Traditional routes of dexamethasone administration provide suboptimal vitreous levels and high systemic concentrations

Journal: Clinical Ophthalmology (Auckland, N.Z.)

Article Title: Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema

doi: 10.2147/OPTH.S15783

Figure Lengend Snippet: Traditional routes of dexamethasone administration provide suboptimal vitreous levels and high systemic concentrations

Article Snippet: The dexamethasone implant was also investigated as a combination therapy with laser photocoagulation in diabetic macular edema patients and with ranibizumab (Lucentis ® , Genentech Inc, San Francisco, CA) in patients with choroidal neovascularization secondary to exudative age-related macular degeneration.

Techniques:

Dexamethasone Posterior Segment Drug Delivery System ® Applicator and approximate vitreous location of dexamethasone implant after insertion. The implant is approximately 6 mm long and is inserted into the vitreous cavity through the 22-gauge needle of the applicator.

Journal: Clinical Ophthalmology (Auckland, N.Z.)

Article Title: Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema

doi: 10.2147/OPTH.S15783

Figure Lengend Snippet: Dexamethasone Posterior Segment Drug Delivery System ® Applicator and approximate vitreous location of dexamethasone implant after insertion. The implant is approximately 6 mm long and is inserted into the vitreous cavity through the 22-gauge needle of the applicator.

Article Snippet: The dexamethasone implant was also investigated as a combination therapy with laser photocoagulation in diabetic macular edema patients and with ranibizumab (Lucentis ® , Genentech Inc, San Francisco, CA) in patients with choroidal neovascularization secondary to exudative age-related macular degeneration.

Techniques:

Temporal kinetics of dexamethasone concentrations in the vitreous cavity, retina, and plasma following placement of the 0.7 mg dexamethasone implant in monkeys. The dexamethasone concentration was below the minimum detection limit in plasma after day 60.

Journal: Clinical Ophthalmology (Auckland, N.Z.)

Article Title: Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema

doi: 10.2147/OPTH.S15783

Figure Lengend Snippet: Temporal kinetics of dexamethasone concentrations in the vitreous cavity, retina, and plasma following placement of the 0.7 mg dexamethasone implant in monkeys. The dexamethasone concentration was below the minimum detection limit in plasma after day 60.

Article Snippet: The dexamethasone implant was also investigated as a combination therapy with laser photocoagulation in diabetic macular edema patients and with ranibizumab (Lucentis ® , Genentech Inc, San Francisco, CA) in patients with choroidal neovascularization secondary to exudative age-related macular degeneration.

Techniques: Clinical Proteomics, Concentration Assay

Percentage of patients with a ≥10-letter or a ≥15-letter improvement in best corrected visual acuity following treatment with the 0.7 mg dexamethasone implant at days 90 and 180. Notes: a P < 0.001, b P = 0.06, c P = 0.006, and d P = 0.02 compared with observation. A P < 0.025 was considered a statistically significant difference. Abbreviation: DEX, dexamethasone.

Journal: Clinical Ophthalmology (Auckland, N.Z.)

Article Title: Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema

doi: 10.2147/OPTH.S15783

Figure Lengend Snippet: Percentage of patients with a ≥10-letter or a ≥15-letter improvement in best corrected visual acuity following treatment with the 0.7 mg dexamethasone implant at days 90 and 180. Notes: a P < 0.001, b P = 0.06, c P = 0.006, and d P = 0.02 compared with observation. A P < 0.025 was considered a statistically significant difference. Abbreviation: DEX, dexamethasone.

Article Snippet: The dexamethasone implant was also investigated as a combination therapy with laser photocoagulation in diabetic macular edema patients and with ranibizumab (Lucentis ® , Genentech Inc, San Francisco, CA) in patients with choroidal neovascularization secondary to exudative age-related macular degeneration.

Techniques:

Efficacy of the dexamethasone implant in improving BCVA stratified by the underlying cause of macular edema in patients who participated in the Phase II trial. Notes: a P not determined; b P = 0.029 and c P = 0.007 compared with the observation group; d uveitis or Irvine-Gass syndrome; e n = 35 for the 0.7 mg dexamethasone implant; f n = 13 for the 0.7 mg dexamethasone implant. Abbreviations: DEX, dexamethasone; BVCA, best corrected visual acuity.

Journal: Clinical Ophthalmology (Auckland, N.Z.)

Article Title: Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema

doi: 10.2147/OPTH.S15783

Figure Lengend Snippet: Efficacy of the dexamethasone implant in improving BCVA stratified by the underlying cause of macular edema in patients who participated in the Phase II trial. Notes: a P not determined; b P = 0.029 and c P = 0.007 compared with the observation group; d uveitis or Irvine-Gass syndrome; e n = 35 for the 0.7 mg dexamethasone implant; f n = 13 for the 0.7 mg dexamethasone implant. Abbreviations: DEX, dexamethasone; BVCA, best corrected visual acuity.

Article Snippet: The dexamethasone implant was also investigated as a combination therapy with laser photocoagulation in diabetic macular edema patients and with ranibizumab (Lucentis ® , Genentech Inc, San Francisco, CA) in patients with choroidal neovascularization secondary to exudative age-related macular degeneration.

Techniques:

Time to achieve 15 letters of improvement from baseline BVCA in patients with macular edema secondary to central retinal vein occlusion or branch retinal vein occlusion who participated in the Phase III trials. Abbreviations: DEX, dexamethasone; BVCA, best corrected visual acuity.

Journal: Clinical Ophthalmology (Auckland, N.Z.)

Article Title: Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema

doi: 10.2147/OPTH.S15783

Figure Lengend Snippet: Time to achieve 15 letters of improvement from baseline BVCA in patients with macular edema secondary to central retinal vein occlusion or branch retinal vein occlusion who participated in the Phase III trials. Abbreviations: DEX, dexamethasone; BVCA, best corrected visual acuity.

Article Snippet: The dexamethasone implant was also investigated as a combination therapy with laser photocoagulation in diabetic macular edema patients and with ranibizumab (Lucentis ® , Genentech Inc, San Francisco, CA) in patients with choroidal neovascularization secondary to exudative age-related macular degeneration.

Techniques:

Mean change from baseline BVCA in patients with macular edema secondary to central retinal vein occlusion or branch retinal vein occlusion who participated in the Phase III trials. Notes: a P ≤ 0.006 compared to sham. Abbreviations: DEX, dexamethasone; BVCA, best corrected visual acuity.

Journal: Clinical Ophthalmology (Auckland, N.Z.)

Article Title: Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema

doi: 10.2147/OPTH.S15783

Figure Lengend Snippet: Mean change from baseline BVCA in patients with macular edema secondary to central retinal vein occlusion or branch retinal vein occlusion who participated in the Phase III trials. Notes: a P ≤ 0.006 compared to sham. Abbreviations: DEX, dexamethasone; BVCA, best corrected visual acuity.

Article Snippet: The dexamethasone implant was also investigated as a combination therapy with laser photocoagulation in diabetic macular edema patients and with ranibizumab (Lucentis ® , Genentech Inc, San Francisco, CA) in patients with choroidal neovascularization secondary to exudative age-related macular degeneration.

Techniques:

Mean change from baseline BCVA stratified by the underlying cause of macular edema of patients who participated in the Phase III trials. Notes: a P < 0.001, b P = 0.008, and c P = 0.305 compared to sham. Abbreviations: DEX, dexamethasone; BVCA, best corrected visual acuity; BRVO, branch retinal vein occlusion; CRVO, central retinal vein occlusion.

Journal: Clinical Ophthalmology (Auckland, N.Z.)

Article Title: Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema

doi: 10.2147/OPTH.S15783

Figure Lengend Snippet: Mean change from baseline BCVA stratified by the underlying cause of macular edema of patients who participated in the Phase III trials. Notes: a P < 0.001, b P = 0.008, and c P = 0.305 compared to sham. Abbreviations: DEX, dexamethasone; BVCA, best corrected visual acuity; BRVO, branch retinal vein occlusion; CRVO, central retinal vein occlusion.

Article Snippet: The dexamethasone implant was also investigated as a combination therapy with laser photocoagulation in diabetic macular edema patients and with ranibizumab (Lucentis ® , Genentech Inc, San Francisco, CA) in patients with choroidal neovascularization secondary to exudative age-related macular degeneration.

Techniques:

A summary of patients’ demographics, comorbidities, presentation, and treatment responses.

Journal: Vaccines

Article Title: Retinal Vein Occlusion after COVID-19 Vaccination—A Review

doi: 10.3390/vaccines11081281

Figure Lengend Snippet: A summary of patients’ demographics, comorbidities, presentation, and treatment responses.

Article Snippet: Romano D et al. [ ] , 54/F , AstraZeneca (2nd) , 20/400 , 2 days , Hypertension , Dexamethasone intravitreal implant, laser pan-retinal photocoagulation , VA: 20/200 , Ischaemic CRVO.

Techniques: Injection